Title 21Food and DrugsRelease 119-83

§399j Abraham Accords Office

Title 21 › Chapter 9— FEDERAL FOOD, DRUG, AND COSMETIC ACT › Subchapter X— MISCELLANEOUS › § 399j

Last updated Apr 18, 2026|Official source

Summary

The Secretary of Health and Human Services, through the FDA Commissioner, must set up an Abraham Accords Office inside the FDA and name a director. No later than 2 years after February 3, 2026, the Secretary must pick a location in an Abraham Accords country, work with those governments and U.S. diplomatic and security staff to open the office there, and assign FDA employees needed to run it. Once open, the office must help regulatory partners in Abraham Accords countries strengthen and align rules for FDA‑regulated products, including good manufacturing practices and other manufacturing issues for medical products. It must also help connect FDA with interested groups in those countries, share information about U.S. regulatory paths, and gather feedback on research, development, and manufacturing. An “Abraham Accords country” means a country the State Department lists as a signatory of the Abraham Accords Declaration. Nothing in these duties requires acting against a federal national security recommendation.

Full Legal Text

Title 21, §399j

Food and Drugs — Source: USLM XML via OLRC

(a)The Secretary, acting through the Commissioner of Food and Drugs, shall establish within the Food and Drug Administration an office, to be known as the Abraham Accords Office, to be headed by a director.
(b)Not later than 2 years after February 3, 2026, the Secretary shall—
(1)in consultation with the governments of Abraham Accords countries, as well as appropriate United States Government diplomatic and security personnel—
(A)select the location of the Abraham Accords Office in an Abraham Accords country; and
(B)establish such office; and
(2)assign to such office such personnel of the Food and Drug Administration as the Secretary determines necessary to carry out the functions of such office.
(c)The Secretary, acting through the Director of the Abraham Accords Office, shall—
(1)after the Abraham Accords Office is established—
(A)as part of the Food and Drug Administration’s work to strengthen the international oversight of regulated commodities, provide technical assistance to regulatory partners in Abraham Accords countries on strengthening regulatory oversight and converging regulatory requirements for the oversight of regulated products, including good manufacturing practices and other issues relevant to manufacturing medical products that are regulated by the Food and Drug Administration; and
(B)facilitate interactions between the Food and Drug Administration and interested parties in Abraham Accords countries, including by sharing relevant information regarding United States regulatory pathways with such parties, and facilitate feedback on the research, development, and manufacturing of products regulated in accordance with this chapter; and
(2)carry out other functions and activities as the Secretary determines to be necessary to carry out this section.
(d)In this section, the term “Abraham Accords country” means a country identified by the Department of State as having signed the Abraham Accords Declaration.
(e)Nothing in this section shall be construed to require any action inconsistent with a national security recommendation provided by the Federal Government.

Legislative History

Notes & Related Subsidiaries

Editorial Notes

Reference

Citations & Metadata

Citation

21 U.S.C. § 399j

Title 21Food and Drugs

Last Updated

Apr 18, 2026

Release point: 119-83